Navigation Links
Mirus Bio awarded patent on RNA delivery

Madison, Wis. - Mirus Bio Corp., a Madison-based company engaged in gene therapy and the study of RNA interference, has been granted a United States patent on a new injection delivery method.

The company has been working to address the lack of an effective method to deliver nucleic acids such as RNA for the study of gene function, and along wit......

Full article >>> This enables regional delivery throughout an entire limb.

"In order for any gene-silencing method to work, one has to not only get them into the body, but you've got to get those compounds into the target cells, where they can do their function," Smestad noted. "We've got an interesting platform that no one else in the world has, so it's very much a cutting-edge technology."

Hydr......

Full article >>> on either up or down depending on what the objective might be."

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 12/15/06


Related biology technology :

1. Mirus Bio secures $900K grant to develop research tool
2. Mirus Bio, Pfizer enter multimillion-dollar research agreement
3. Mirus granted European patent for gene therapy
4. Mirus provides low-cost way to modify genes
5. Mirus announces new method for making antibodies
6. Platypus adds Mirus VP to board of directors
7. Mirus receives $1.26 million SBIR grant to combat anemia
8. Small Tree Communications awarded $2.85M defense contract
9. Alfalight awarded $1.7M from Army Research Lab
10. UW Biomedical Engineering awarded $2.9 million research grant
11. Two companies awarded state tech grants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):